ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Cuttlefish Ink-Derived Melanin/MXene Composites: Boosting Stability and Unleashing Synergistic Photothermal-Mechanical Antimicrobial Effects Against Biofilms.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The advancement of MXene-based antibacterial platforms has been impeded by two critical limitations. Specifically, these include rapid oxidative degradation in physiological environments and potential cytotoxicity derived from their metallic nature. To address these challenges, we develop a core-shell structured nanikohybrid (CI@MXene) through the integration of natural cuttlefish ink melanin (CI) with MXene nanosheets. This biomimetic design establishes a protective barrier that effectively prevents MXene oxidation, thereby preserving its structural integrity and granting it durable antibacterial activity with sustained efficacy even after prolonged storage. Furthermore, the composite enables a mild photothermal therapy (PTT) under near-infrared irradiation, maintaining skin temperature below 45°C. This gentle thermal effect synergizes with the preserved nano-knife capability of the encapsulated MXene, resulting in remarkable eradication rates exceeding 95% against both E. coil and S. aureus, along with approximately 80% disruption of established biofilms. More importantly, in vivo evaluation using a murine wound infection model demonstrated accelerated wound closure, significantly reduced bacterial burden, and attenuated inflammatory responses, accompanied by enhanced tissue regeneration. This work not only provides fundamental insights into the rational design of stable and biosafe MXene-based nanomaterials but also establishes a novel strategy for synergistic physical antibacterial therapy, offering a promising approach for combating biofilm-associated infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.